Guidance published in eClinicalMedicine – The Lancet Discovery Science for management of patients with ovarian immature teratoma, a rare type of germ cell tumour. Not possible without great teamwork with Malignant Germ Cell International Consortium colleagues, including Joanna Gell and Michelle Lockley. Cambridge University Hospitals NHS CRUK Cambridge Centre CRUK Cambridge Centre: Paediatric Cancer 🎗️ CRUK Cambridge Centre: Ovarian Cancer

At the Malignant Germ Cell International Consortium 2023 Annual Meeting in Edinburgh. Identifying new clinical and biological studies to improve outcomes for patients with germ cell tumours #GCT Thanks to Children’s Cancer and Leukaemia Group and CRUK Cambridge Centre: Paediatric Cancer 🎗️ for support Cambridge University Hospitals NHS Cambridge Pathology CRUK Cambridge Centre: Urological Malignancies CRUK Cambridge Centre

Latest MaGIC work on germ cell tumours out now:
⁦Adriana Fonseca⁩ ⁦João Lobo⁩ ⁦DrBagrodia⁩ ⁦Michelle Lockley⁩ ⁦Malignant Germ Cell International Consortium⁩ ⁦Cambridge University Hospitals NHS⁩ ⁦Cambridge Pathology⁩ ⁦CRUK Cambridge Centre⁩ #biobanks #testicularcancer #TGCT nature.com/articles/s4141…

A MaGIC-al moment at the recent #SIOP2022 Meeting in Barcelona!

Lindsay Frazier Ana Glenda Vieira SIOP International

Published today online by the Malignant Germ Cell International Consortium #Pathology group. Relevant to #OBGYNPath and #PediPath too. UPMC Pathology Residency Program Addressing the diagnostic and therapeutic dilemmas of ovarian immature... sciencedirect.com/science/articl…

Very special to be Indiana University for the Malignant Germ Cell International Consortium meeting, hearing about #testicularcancer management from the great Dr. Larry Einhorn. His work changed the field and has saved countless lives. #legend

Privileged to be in audience hearing Lawrence Einhorn in Indianapolis give a more than four decade overview of the treatment of germ cell tumours, including his introduction of combination cisplatin-based chemotherapy which transformed outcomes. Malignant Germ Cell International Consortium #tgct

#SGOMtg Great talk by Mark Krailo challenging all of us to continue to innovate HOW we conduct clinical trials in rare tumors!

Dr. Gell's project, 'Development of a targeted compound for the germ cell tumor marker PRDM14 ', was chosen for funding as a CureSearch Young Investigator Award. Congrats, Joanna!! Joanna Gell

Congratulations to Dr. Anne Lindsay Frazier @drlindsfrazie of Dana-Farber and Harvard University --
Recognized as an Expertscape Expert in Ovarian Cancer.

expertscape.com/ex/ovarian+neo…

MaGIC is excited to have recently added patient advocates to our membership! Please join Dr. Forster on November 4th at 1 pm EDT on “Patient involvement in research: How to effectively integrate patients, survivors and caregivers into research teams” Message us for login info!

Great keynote presentation on MaGIC by James Nicholson at the 53rd SIOP congress! #SIOP2021 Children’s Cancer and Leukaemia Group Malignant Germ Cell International Consortium SIOP International